Develops proprietary genomic editors that target the root causes of genetic diseases by selecting optimal editing tools based on disease-specific pathology. This approach enables the discovery and development of potentially curative genomic medicines, with a focus on liver and central nervous system disorders.
Funding
$230.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
ABTHFounders
Product
Problem
Many genetic diseases lack effective treatments that address the underlying cause, often requiring lifelong management of symptoms. Current gene editing technologies may have limitations in terms of precision, delivery, or the range of diseases they can address. This creates a need for more versatile and targeted gene editing tools to develop curative therapies for a wider spectrum of genetic disorders.
Solution
Arbor Biotechnologies is developing a suite of next-generation gene editing technologies to target the root causes of genetic diseases. Their approach involves selecting and optimizing gene editing tools based on the specific pathology of each disease, enabling the discovery and development of potentially curative genomic medicines. The company is focused on advancing therapies for liver and central nervous system (CNS) disorders, leveraging a diverse toolbox of novel gene editors to rewrite the human genome and achieve functional cures.
Target Audience
The primary target audience includes patients suffering from genetic diseases, their families, and healthcare providers seeking curative treatment options.
Features
- Proprietary platform for discovering and developing novel gene editors with enhanced specificity and efficiency
- Disease-specific selection of optimal editing tools based on comprehensive genomic analysis
- Focus on in vivo gene editing for targeted delivery and long-term therapeutic effects
- Development of gene editing therapies for liver and central nervous system disorders
- Modular editing systems that can be customized to address a wide range of genetic mutations